Immune-neuro-endocrine interactions: facts and hypotheses.

[1]  P. Medawar,et al.  The effects of adrenocortical hormones, adrenocorticotrophic hormone and pregnancy on skin transplantation immunity in mice. , 1956, The Journal of endocrinology.

[2]  E. Kwan,et al.  T cell-derived glucosteroid response-modifying factor (GRMFT): a unique lymphokine made by normal T lymphocytes and a T cell hybridoma. , 1984, Journal of immunology.

[3]  A. Sjögren,et al.  Interleukin-1 alpha modulates luteinizing hormone stimulated cyclic AMP and progesterone release from human granulosa cells in vitro. , 1991, Human Reproduction.

[4]  J. Pomposelli,et al.  Infusion of tumor necrosis factor/cachectin promotes muscle catabolism in the rat. A synergistic effect with interleukin 1. , 1989, The Journal of clinical investigation.

[5]  Y. Ito,et al.  Inhibition of 125I organification and thyroid hormone release by interleukin-1, tumor necrosis factor-alpha, and interferon-gamma in human thyrocytes in suspension culture. , 1990, The Journal of clinical endocrinology and metabolism.

[6]  J. D. Albert,et al.  Shock and tissue injury induced by recombinant human cachectin. , 1986, Science.

[7]  S. Felten,et al.  Alterations of monoamines in specific central autonomic nuclei following immunization in mice , 1987, Brain, Behavior, and Immunity.

[8]  F. Fitch,et al.  Histologic Localization of Hemolysin-Containing Cells , 1969 .

[9]  S. Nagataki,et al.  Interleukin-1 inhibits thyrotrophin-induced human thyroglobulin gene expression. , 1989, The Journal of endocrinology.

[10]  G. Zbinden,et al.  Effects of interferons and hydrogen peroxide on CA3 pyramidal cells in rat hippocampal slice cultures , 1993, Brain Research.

[11]  D. Doniach,et al.  Binding of human immunoglobulins to pituitary ACTH cells , 1976, Nature.

[12]  H. Nakamura,et al.  Involvement of corticotropin-releasing factor in the antinociception produced by interleukin-1 in mice. , 1993, European journal of pharmacology.

[13]  A. Kavelaars,et al.  The role of IL-1 in the corticotropin-releasing factor and arginine- vasopressin-induced secretion of immunoreactive beta-endorphin by human peripheral blood mononuclear cells. , 1989, Journal of immunology.

[14]  H. Lassmann,et al.  Cellular immune reactivity within the CNS , 1986, Trends in Neurosciences.

[15]  H. Besedovsky,et al.  Interleukin 1 affects glucose homeostasis. , 1987, The American journal of physiology.

[16]  W. Hickey,et al.  T‐lymphocyte entry into the central nervous system , 1991, Journal of neuroscience research.

[17]  H. Nawa,et al.  Neuronal differentiation factors/cytokines and synaptic plasticity , 1993, Cell.

[18]  A. Dunn,et al.  Systemic interleukin-1 administration stimulates hypothalamic norepinephrine metabolism parallelling the increased plasma corticosterone. , 1988, Life sciences.

[19]  G. Kroemer,et al.  Immunoendocrine communication via the hypothalamo-pituitary-adrenal axis in autoimmune diseases. , 1993, Endocrine reviews.

[20]  A. Strosberg.  Chapter 19 – Antiidiotypic Antibodies as Immunological Internal Images of Hormones , 1984 .

[21]  J. Borrell,et al.  Release of corticotropin-releasing factor from superfused rat hypothalami induced by interleukin-1 is not dependent on adrenergic mechanism. , 1992, European journal of pharmacology.

[22]  P. MohanKumar,et al.  Interleukin-1 stimulates the release of dopamine and dihydroxyphenylacetic acid from the hypothalamus in vivo. , 1991, Life sciences.

[23]  J. Leonard,et al.  Hypothalamic noradrenergic pathways exert an influence on neuroendocrine and clinical status in experimental autoimmune encephalomyelitis , 1991, Brain, Behavior, and Immunity.

[24]  H. Ovadia,et al.  Central administration of immunomodulatory factors alters neural activity and adrenocortical secretion , 1989, Brain, Behavior, and Immunity.

[25]  G. Jonakait,et al.  Conditioned medium from activated splenocytes increases substance P in sympathetic ganglia , 1990, Journal of neuroscience research.

[26]  G. Chrousos,et al.  Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis-susceptible Lewis rats. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[27]  H. Besedovsky,et al.  Thymus involvement in female sexual maturation , 1974, Nature.

[28]  D. Cardinali,et al.  Local regulation of the immune response by the autonomic nervous system. , 1994, Neuroimmunomodulation.

[29]  M. R. Yelich.  In vivo endotoxin and IL-1 potentiate insulin secretion in pancreatic islets. , 1990, The American journal of physiology.

[30]  A. Dunn.  Endotoxin-induced activation of cerebral catecholamine and serotonin metabolism: comparison with interleukin-1. , 1992, The Journal of pharmacology and experimental therapeutics.

[31]  B. D. Clark,et al.  Suppression of thyrotropin-releasing hormone gene expression by interleukin-1-beta in the rat: implications for nonthyroidal illness. , 1994, Neuroendocrinology.

[32]  H. Besedovsky,et al.  Antigenic competition between horse and sheep red blood cells as a hormone-dependent phenomenon. , 1979, Clinical and experimental immunology.

[33]  J. Seyer,et al.  Interleukin 1 receptor antagonist blocks somnogenic and pyrogenic responses to an interleukin 1 fragment. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[34]  S. Levine,et al.  Effects of Experimental Allergic Encephalomyelitis on Thymus and Adrenal: Relation to Remission and Relapse 1 , 1980, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[35]  J. Filkins,et al.  Mechanism of hyperinsulinemia after reticuloendothelial system phagocytosis. , 1982, The American journal of physiology.

[36]  S. Kalra,et al.  Interleukin-1 inhibits the ovarian steroid-induced luteinizing hormone surge and release of hypothalamic luteinizing hormone-releasing hormone in rats. , 1990, Endocrinology.

[37]  R. Dantzer,et al.  Different receptor mechanisms mediate the pyrogenic and behavioral effects of interleukin 1. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[38]  K. Federlin,et al.  Adrenal secretion of cortisol in patients with rheumatoid arthritis. , 1990, The Journal of rheumatology.

[39]  M. R. Yelich.  Effects of Endotoxin and Interleukin‐1 on Glucagon and Insulin Secretion from the Perfused Rat Pancreas , 1992, Pancreas.

[40]  J. Balibrea,et al.  Cytokine‐Induced Inhibition of Lipid Synthesis and Hormone Secretion by Isolated Human Islets , 1994, Pancreas.

[41]  E. Benveniste.  Cytokines: influence on glial cell gene expression and function. , 1992, Chemical immunology.

[42]  C. Galanos,et al.  Monoclonal antibody to tumor necrosis factor--alpha prevents lethal endotoxin sepsis in adult rhesus monkeys. , 1992, The Journal of laboratory and clinical medicine.

[43]  S. A. Hoffman,et al.  Effects of Peripheral Cytokine Injections on Multiple Unit Activity in the Anterior Hypothalamic Area of the Mouse , 1993, Brain, Behavior, and Immunity.

[44]  E. Faragher,et al.  Inflammatory cytokines stimulate glucose uptake and glycolysis but reduce glucose oxidation in human dermal fibroblasts in vitro. , 1992, Circulatory shock.

[45]  F. Eusebi,et al.  Tumor necrosis factor alters synaptic transmission in rat hippocampal slices , 1992, Neuroscience Letters.

[46]  H. Ovadia,et al.  Selective facilitation of putative corticotropin-releasing factor-secreting neurones by interleukin-1 , 1990, Neuroscience Letters.

[47]  W. Arend.  Interleukin-1 receptor antagonist. , 1993, Advances in immunology.

[48]  T. van der Poll,et al.  Tumor necrosis factor: a putative mediator of the sick euthyroid syndrome in man. , 1990, The Journal of clinical endocrinology and metabolism.

[49]  E. Sorkin,et al.  Immunoregulation mediated by the sympathetic nervous system, II. , 1979, Cellular immunology.

[50]  S. Sandler,et al.  Inhibitory effects of interleukin 1 on insulin secretion, insulin biosynthesis, and oxidative metabolism of isolated rat pancreatic islets. , 1987, Endocrinology.

[51]  A. Dunn,et al.  Noradrenergic innervation of the hypothalamus participates in adrenocortical responses to interleukin-1. , 1992, Neuroendocrinology.

[52]  R. Aston,et al.  Antibody-mediated enhancement of hormone activity. , 1989, Molecular immunology.

[53]  H. Haas,et al.  Hypothalamic changes during the immune response. , 1977, European journal of immunology.

[54]  T. Hori,et al.  Actions of interferon alpha and interleukin- 1 beta on the glucose-responsive neurons in the ventromedial hypothalamus. , 1990, Brain research bulletin.

[55]  M. Hill,et al.  Human recombinant IL-1 alters glucocorticoid receptor function in Reuber hepatoma cells. , 1988, Journal of immunology.

[56]  G. Warnock,et al.  Cytotoxic effects of cytokines on human pancreatic islet cells in monolayer culture. , 1990, The Journal of clinical endocrinology and metabolism.

[57]  G. Siggins,et al.  Interleukin 1β inhibits synaptic strength and long-term potentiation in the rat CA1 hippocampus , 1993, Brain Research.

[58]  R. Fässler,et al.  Disturbed immune-endocrine communication in autoimmune disease. Lack of corticosterone response to immune signals in obese strain chickens with spontaneous autoimmune thyroiditis. , 1987, Journal of immunology.

[59]  G. Siggins,et al.  Interleukin-1β increases synaptic inhibition in rat hippocampal pyramidal neurons in vitro , 1992, Regulatory Peptides.

[60]  D. Saphier.  Neurophysiological and endocrine consequences of immune activity , 1989, Psychoneuroendocrinology.

[61]  L. Moldawer,et al.  Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[62]  F. Eusebi,et al.  Interferon inhibits synaptic potentiation in rat hippocampus , 1991, Brain Research.

[63]  Y. Oomura,et al.  The effects of interleukin-1 beta on the activity of adrenal, splenic and renal sympathetic nerves in the rat. , 1991, Journal of the autonomic nervous system.

[64]  H. Besedovsky,et al.  Metabolic and neuroendocrine effects of pro-inflammatory cytokines. , 1992, European journal of clinical investigation.

[65]  D. Baly,et al.  Interleukin‐1 stimulates glucose transport in rat adipose cells , 1990 .

[66]  A. Fauci,et al.  Activation of human B lymphocytes. IV. Regulatory effects of corticosteroids on the triggering signal in the plaque-forming cell response of human peripheral blood B lymphocytes to polyclonal activation. , 1977, Journal of Immunology.

[67]  E. Vizi,et al.  Presynaptic inhibitory effect of TNF-α on the release of noradrenaline in isolated median eminence , 1992, Journal of Neuroimmunology.

[68]  K. Roby,et al.  Effects of tumor necrosis factor-alpha in vitro on steroidogenesis of healthy and atretic follicles of the rat: theca as a target. , 1990, Endocrinology.

[69]  H. Besedovsky,et al.  Antidiabetic effects of interleukin 1. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[70]  C. Lang,et al.  Gram-negative infection increases noninsulin-mediated glucose disposal. , 1991, Endocrinology.

[71]  E. Adashi,et al.  Cytokine-mediated regulation of ovarian function: tumor necrosis factor alpha inhibits gonadotropin-supported progesterone accumulation by differentiating and luteinized murine granulosa cells. , 1990, American journal of obstetrics and gynecology.

[72]  N. Rothwell.  CRF is involved in the pyrogenic and thermogenic effects of interleukin 1 beta in the rat. , 1989, The American journal of physiology.

[73]  S. Bevan,et al.  Inflammation and hyperalgesia: highlighting the team effort. , 1993, Trends in pharmacological sciences.

[74]  N. Rothwell,et al.  Functions and mechanisms of interleukin 1 in the brain. , 1991, Trends in pharmacological sciences.

[75]  S. Freier,et al.  Effect of cholecystokinin and of its antagonist, of atropine, and of food on the release of immunoglobulin A and immunoglobulin G specific antibodies in the rat intestine. , 1987, Gastroenterology.

[76]  N. Van Rooijen,et al.  Selective depletion of macrophages prevents pituitary-adrenal activation in response to subpyrogenic, but not to pyrogenic, doses of bacterial endotoxin in rats. , 1991, Endocrinology.

[77]  S. Nagataki,et al.  Interleukin 6 inhibits human thyroid peroxidase gene expression. , 1991, Acta endocrinologica.

[78]  A. Grossman,et al.  Interleukin-1 directly stimulates the release of corticotrophin releasing factor from rat hypothalamus. , 1989, Neuroendocrinology.

[79]  L. Bradley,et al.  Selective protection of murine thymic helper T cells from glucocorticosteroid inhibition by macrophage-derived mediators. , 1982, Cellular immunology.

[80]  G. Nisticó,et al.  Behavioral and Electrocortical Spectrum Power Effects after Microinfusion of Lymphokines in Several Areas of the Rat Brain , 1991, Annals of the New York Academy of Sciences.

[81]  M. Swain,et al.  Effect of Inflammation of Enteric Nerves Cytokine‐Induced Changes in Neurotransmitter Content and Release a , 1992, Annals of the New York Academy of Sciences.

[82]  K. Nakano,et al.  Significance of increased secretion of glucocorticoids in mice and rats injected with bacterial endotoxin , 1987, Brain, Behavior, and Immunity.

[83]  S. Collins,et al.  Interleukin-1 beta modulation of norepinephrine release from rat myenteric nerves. , 1993, The American journal of physiology.

[84]  S. Kanba,et al.  Interleukin-1 beta augments release of norepinephrine, dopamine, and serotonin in the rat anterior hypothalamus , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[85]  C. Vedeler.  Demonstration of Fc gamma receptors on human peripheral nerve fibres. , 1987, Journal of neuroimmunology.

[86]  D. Larson,et al.  Freund's complete adjuvant induces ornithine decarboxylase activity in the central nervous system of male rats and triggers the release of pituitary hormones , 1990, Journal of Neuroimmunology.

[87]  H. Besedovsky,et al.  Interleukin-1 induces changes in norepinephrine metabolism in the rat brain , 1988, Brain, Behavior, and Immunity.

[88]  M. Kluger.  Fever: Role of Pyrogens and Cryogens , 1991, Physiological reviews.

[89]  J. Polak,et al.  Regulatory peptides of the gastrointestinal and respiratory tracts. , 1986, Archives internationales de pharmacodynamie et de therapie.

[90]  K. Kelley,et al.  Newcastle disease virus-infected splenocytes express the proopiomelanocortin gene , 1986, The Journal of experimental medicine.

[91]  M. Powanda,et al.  Phagocytosis and the metabolic sequelae of infection. , 1980, Journal of the Reticuloendothelial Society.

[92]  N. Hall,et al.  Thymic Hormones and Immune Function: Mediation via Neuroendocrine Circuits , 1991 .

[93]  H. Besedovsky,et al.  Interactions Between Endogenous Glucocorticoids and Inflammatory Responses in Normal and Tumor‐Bearing Mice: Role of T Cells , 1988, Journal of leukocyte biology.

[94]  S. Asa,et al.  Vasoactive intestinal peptide-containing nerves in Peyer's patches , 1987, Brain, Behavior, and Immunity.

[95]  J. Leonard,et al.  Changes in lymphocyte β-adrenergic receptor density and noradrenaline content of the spleen are early indicators of immune reactivity in acute experimental allergic encephalomyelitis in the Lewis rat , 1989, Journal of Neuroimmunology.

[96]  J. Zadina,et al.  Interleukin-1 activation of FOS proto-oncogene protein in the rat hypothalamus , 1993, Brain Research.

[97]  B. Fauser,et al.  Inhibitory actions of interleukin-1 beta on steroidogenesis in primary cultures of neonatal rat testicular cells. , 1989, Acta endocrinologica.

[98]  H. Ovadia,et al.  Multiunit electrical activity in conscious rats during an immune response , 1987, Brain, Behavior, and Immunity.

[99]  C. Plata-salamán,et al.  Interleukin-1β depresses calcium currents in CA1 hippocampal neurons at pathophysiological concentrations , 1992, Brain Research Bulletin.

[100]  Å. Lernmark,et al.  Interleukin-1 potentiates glucose stimulated insulin release in the isolated perfused pancreas. , 1988, Acta endocrinologica.

[101]  H. Besedovsky,et al.  Changes in plasma hormone profiles after tumor transplantation into syngeneic and allogeneic rats , 1985, International journal of cancer.

[102]  M. Moskowitz,et al.  Conditioned media from activated lymphocytes maintain sympathetic neurons in culture. , 1982, Brain research.

[103]  S. Szefler,et al.  Combination IL-2 and IL-4 reduces glucocorticoid receptor-binding affinity and T cell response to glucocorticoids. , 1993, Journal of immunology.

[104]  B. Beutler,et al.  Cachectin/tumor necrosis factor: production, distribution, and metabolic fate in vivo. , 1985, Journal of immunology.

[105]  H. Nakane,et al.  An Interleukin-1β-Induced Noradrenaline Release in the Spleen Is Mediated by Brain Corticotropin-Releasing Factor: An in Vivo Microdialysis Study in Conscious Rats , 1994, Brain, Behavior, and Immunity.

[106]  A. Kung,et al.  Interleukin-1 beta modulates thyrotropin-induced thyroglobulin mRNA transcription through 3',5'-cyclic adenosine monophosphate. , 1990, Endocrinology.

[107]  S. Felten,et al.  Splenic Norepinephrine Is Decreased in MRL-lpr/lpr Mice , 1993, Brain, Behavior, and Immunity.

[108]  H. Besedovsky,et al.  Hormonal changes following tumor transplantation: Factors increasing corticosterone and the relationship of corticosterone to tumor‐induced anti‐inflammation , 1988, International journal of cancer.

[109]  S. Martin,et al.  Functional and morphological effects of interleukin-1 beta on the perfused rat pancreas. , 1990, Diabetologia.

[110]  H. Besedovsky,et al.  The bursa of Fabricius is required for normal endocrine development in chicken. , 1980, General and comparative endocrinology.

[111]  H. Anisman,et al.  Cytokine-specific central monoamine alterations induced by interleukin-1, -2 and -6 , 1994, Brain Research.

[112]  W. Vale,et al.  Cytokines act within the brain to inhibit luteinizing hormone secretion and ovulation in the rat. , 1990, Endocrinology.

[113]  C. Brosnan,et al.  Proliferation of astrocytes in vitro in response to cytokines. A primary role for tumor necrosis factor. , 1990, Journal of immunology.

[114]  D. Mason,et al.  Spontaneous recovery of rats from experimental allergic encephalomyelitis is dependent on regulation of the immune system by endogenous adrenal corticosteroids , 1989, The Journal of experimental medicine.

[115]  A. Dunn,et al.  Stress‐and Endotoxin‐Induced Increases in Brain Tryptophan and Serotonin Metabolism Depend on Sympathetic Nervous System Activity , 1991, Journal of neurochemistry.

[116]  C. Dinarello.  The role of interleukin-1 in host responses to infectious diseases. , 1992, Infectious agents and disease.

[117]  H. Besedovsky,et al.  Interleukin-1 and glucose homeostasis: an example of the biological relevance of immune-neuroendocrine interactions. , 1989, Hormone research.

[118]  H. Klocker,et al.  Analysis of the immune‐encodrine feedback loop in the avian system and its alteration in chickens with spontaneous autoimmune thyroiditis , 1990, European journal of immunology.

[119]  J. Mazié,et al.  Hormonal regulation of the immune response. I. Induction of an immune response in vitro with lymphoid cells from mice exposed to acute systemic stress. , 1971, Cellular immunology.

[120]  R. Newman,et al.  The effect of macrophage conditioned media on Leydig cell function. , 1994, Annals of clinical and laboratory science.

[121]  R. Hart,et al.  Interferon-γ promotes cholinergic differentiation of embryonic septal nuclei and adjacent basal forebrain , 1994, Neuron.

[122]  W. Beisel,et al.  Magnitude of the host nutritional responses to infection. , 1977, The American journal of clinical nutrition.

[123]  M. Masana,et al.  Indomethacin prevents increased catecholamine turnover in rat brain following systemic endotoxin challenge , 1990, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[124]  D. Palazzolo,et al.  Interleukin-1 stimulates catecholamine release from the hypothalamus. , 1990, Life sciences.

[125]  K. Kasono,et al.  Effect of interleukin-1 (IL-1) on thyroid hormone metabolism in mice: stimulation by IL-1 of iodothyronine 5'-deiodinating activity (type I) in the liver. , 1989, Endocrinology.

[126]  C. Blatteis,et al.  Human recombinant tumor necrosis factor and interferon affect the activity of neurons in the organum vasculosum laminae terminalis , 1991, Brain Research.

[127]  H. Shimizu,et al.  Inhibited insulin secretion by recombinant human interleukin-1 beta in adrenalectomized rats: involvement of prostaglandin. , 1990, Biochemical and biophysical research communications.

[128]  G. Risbridger,et al.  The effect of testicular macrophages and interleukin-1 on testosterone production by purified adult rat Leydig cells cultured under in vitro maintenance conditions. , 1993, Endocrinology.

[129]  G. Jonakait,et al.  Substance P gene expression is regulated by interleukin‐1 in cultured sympathetic ganglia , 1991, Journal of neuroscience research.

[130]  A. Dunn,et al.  Effects of Newcastle disease virus administration to mice on the metabolism of cerebral biogenic amines, plasma corticosterone, and lymphocyte proliferation , 1987, Brain, Behavior, and Immunity.

[131]  T. Okumura,et al.  Indomethacin reverses interleukin-1-induced hyperinsulinemia in conscious and freely moving rats. , 1991, European Journal of Pharmacology.

[132]  H. Besedovsky,et al.  Metabolic and Endocrine Actions of Interleukin‐1. , 1990, Annals of the New York Academy of Sciences.

[133]  P. Sawchenko,et al.  A functional anatomical analysis of central pathways subserving the effects of interleukin-1 on stress-related neuroendocrine neurons , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[134]  C. Dinarello,et al.  Interleukin-1 augments gamma-aminobutyric acidA receptor function in brain. , 1991, Molecular pharmacology.

[135]  L. Moldawer.  Interleukin-1, TNFα and their naturally occurring antagonists in sepsis , 1993 .

[136]  R. Norman,et al.  Ovulatory effect of interleukin-1 beta on the perfused rat ovary. , 1993, Endocrinology.

[137]  S. Matta,et al.  The adrenocorticotropin response to interleukin-1 beta instilled into the rat median eminence depends on the local release of catecholamines. , 1990, Endocrinology.

[138]  B. Spiegelman,et al.  Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. , 1993, Science.

[139]  A. Chang,et al.  Lethal Staphylococcus aureus-induced shock in primates: prevention of death with anti-TNF antibody. , 1992, The Journal of trauma.

[140]  A. Pearse,et al.  Embryology of the diffuse neuroendocrine system and its relationship to the common peptides. , 1979, Federation proceedings.

[141]  S. Nagataki,et al.  Interferon-gamma inhibition of human thyrotropin receptor gene expression. , 1993, The Journal of clinical endocrinology and metabolism.

[142]  G. Jonakait,et al.  Interleukin-1 induces substance P in sympathetic ganglia through the induction of leukemia inhibitory factor (LIF) , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[143]  D. Dyck,et al.  Immunopharmacological Tolerance as a Conditioned Response: Dissecting the Brain–Immune Pathways , 1991 .

[144]  C. Kilts,et al.  Brain IL-1-induced immunosuppression occurs through activation of both pituitary-adrenal axis and sympathetic nervous system by corticotropin- releasing factor , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[145]  P. Ghezzi,et al.  Activation of the hypothalamic serotoninergic system by central interleukin-1. , 1991, European journal of pharmacology.

[146]  R. Dantzer,et al.  Sickness behavior as a new target for drug development. , 1992, Trends in pharmacological sciences.

[147]  J. Nerup,et al.  Low concentrations of interleukin-1 stimulate and high concentrations inhibit insulin release from isolated rat islets of Langerhans. , 1986, Acta endocrinologica.

[148]  Filkins Jp.  Endotoxin-enhanced secretion of macrophage insulin-like activity. , 1980 .

[149]  M. Kawakami,et al.  Effects of tumor necrosis factor-alpha/cachectin on thyroid hormone metabolism in mice. , 1988, Endocrinology.

[150]  D. Nance,et al.  Central administration of interleukin-1β increases norepinephrine turnover in the spleen , 1993, Brain Research Bulletin.

[151]  R. Horton,et al.  Tumor necrosis factor and interleukin-1 stimulate testosterone secretion in adult male rat Leydig cells in vitro. , 1990, Journal of andrology.

[152]  J. Cohen,et al.  Role of interferon-gamma in experimental gram-negative sepsis. , 1992, The Journal of infectious diseases.

[153]  D. Anderson,et al.  Modulation of Human Granulosa Cell Steroid Production In Vitro by Tumor Necrosis Factor Alpha: Implications of White Blood Cells in Culture , 1994, Obstetrics and gynecology.

[154]  H. Guo,et al.  Interleukin-2 is a potent inhibitor of Leydig cell steroidogenesis. , 1990, Endocrinology.

[155]  M. Saito,et al.  Tissue-specific increase in norepinephrine turnover by central interleukin-1, but not by interleukin-6, in rats. , 1994, The American journal of physiology.

[156]  T. Strom,et al.  A close relationship between cytotoxic T lymphocytes generated in the mixed lymphocyte culture and insulin receptor-bearing lymphocytes: enrichment by density gradient centrifugation. , 1979, Cellular immunology.

[157]  N. Dafny,et al.  Alpha and gamma interferons' effects on cortical and hippocampal neurons: microiontophoretic application and single cell recording. , 1984, The International journal of neuroscience.

[158]  C. Plata-salamán.  Immunomodulators and feeding regulation: A humoral link between the immune and nervous systems , 1989, Brain, Behavior, and Immunity.

[159]  G. Clark,et al.  Selective effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin and corticosteroid on in vitro lymphocyte maturation. , 1988, Journal of immunology.

[160]  D. Musher,et al.  Hypoglycemia as a manifestation of sepsis. , 1980, The American journal of medicine.

[161]  W. Silvers,et al.  Regulation of pro-opiomelanocortin biosynthesis and processing by transplantation immunity , 1989, Nature.

[162]  J. Nerup,et al.  Cytotoxicity of human pI 7 interleukin-1 for pancreatic islets of Langerhans. , 1986, Science.

[163]  M. Maffei,et al.  Positional cloning of the mouse obese gene and its human homologue , 1995, Nature.

[164]  C H Lang,et al.  Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output. , 1992, Endocrinology.

[165]  C. Sweep,et al.  Chronic infusion of TNF-alpha reduces plasma T4 binding without affecting pituitary-thyroid activity in rats. , 1992, The American journal of physiology.

[166]  L. Wartofsky,et al.  Inhibition of TSH activation of human cultured thyroid cells by tumor necrosis factor: an explanation for decreased thyroid function in systemic illness? , 1991, Thyroid : official journal of the American Thyroid Association.

[167]  P. Shek,et al.  Neuroendocrine regulation of immune processes: change in circulating corticosterone levels induced by the primary antibody response in mice. , 1983, International journal of immunopharmacology.

[168]  M. Stenzel-Poore,et al.  Relationship between antigen-induced immune stimulation and activation of the hypothalamic-pituitary-adrenal axis in the rat. , 1993, Endocrinology.

[169]  P. Heinrich,et al.  Disturbed immuno-endocrine communication via the hypothalamo-pituitary-adrenal axis in autoimmune disease. , 1993, International archives of allergy and immunology.

[170]  T. Tabira,et al.  Trophic effect of erythropoietin and other hematopoietic factors on central cholinergic neurons in vitro and in vivo , 1993, Brain Research.

[171]  P. L. Krohn,et al.  Effect of Cortisone on Survival of Skin Homografts in Rabbits , 1951, British medical journal.

[172]  K. Inenaga,et al.  GABAergic inputs modulate effects of interleukin-1 beta on supraoptic neurones in vitro. , 1993, Neuroreport.

[173]  J. Merrill,et al.  Tumor necrosis factor alpha, interleukin 1 and related cytokines in brain development: normal and pathological. , 1992, Developmental neuroscience.

[174]  K. Mealy,et al.  The testicular effects of tumor necrosis factor. , 1990, Annals of surgery.

[175]  F. Pociot,et al.  Intra-peritoneal administration of interleukin-1 beta induces impaired insulin release from the perfused rat pancreas. , 1990, Autoimmunity.

[176]  S. Reichlin,et al.  THYROID FUNCTION IN EXPERIMENTAL STREPTOCOCCAL PNEUMONIA IN THE RAT , 1958, The Journal of experimental medicine.